tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX

Protagonist Therapeutics (PTGX) Revenue

Compare
733 Followers

Protagonist Therapeutics Revenue

Protagonist Therapeutics had a revenue of 7.44M in the quarter ending Dec 31, 2025, with 57.83%. This bring the company's revenue in the last twelve months to 46.02M, Increased -78.01%. In the fiscal year ending Dec 31, 2025, Protagonist Therapeutics had annual revenue of 46.02M with -89.41% growth.
Revenue (ttm)
46.02M
Revenue Growth
-35.39%
P/S Ratio
134.83
Revenue/Employee
$371,097
Employees
124
Market Cap
$6.20B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
46.02M-388.42M-89.41%
Dec 31, 2024
434.43M374.43M+624.06%
Dec 31, 2023
60.00M33.42M+125.73%
Dec 31, 2022
26.58M-776.00K-2.84%
Dec 31, 2021
27.36M-1.27M-4.44%
Dec 31, 2020
28.63M28.40M+12,293.07%
Dec 31, 2019
231.00K-30.69M-99.25%
Dec 31, 2018
30.93M10.86M+54.14%
Dec 31, 2017
20.06M